Delivery Order SPE2DR25D3013-SPE2DR26F6T5D
Award Date 12/1/25
Potential Completion Date 12/2/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,073.56 to AmerisourceBergen Drug Corp for VIMPAT 150 mg tablets (60 unit dose tablets) on October 21, 2025, with a completion date of October 22, 2025. This is a firm fixed-price, non-set-aside contract with performance in Conshohocken, Pennsylvania. The award represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and...
- The Defense Logistics Agency has awarded a delivery order valued at $1,221.44 to AmerisourceBergen Drug Corp for VIMPAT 150 mg tablets (60-count units). This is a firm fixed price, competitively awarded delivery order with no set-aside designation, issued on October 20, 2025, and scheduled for completion by October 21, 2025. The pharmaceutical product will be delivered to the company's location in Conshohocken, Pennsylvania. VIMPAT (lacosamide) is a controlled anticonvulsant medication used in...
- AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, was awarded a competitive delivery order by the Defense Logistics Agency (DLA) on October 28, 2025, for the supply of VIMPAT 150 mg tablets (60 tablets) valued at $1,255.40. This award is a firm fixed-price delivery order with an ultimate completion date of October 29, 2025, and carries no set-aside designation. The contract represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for VIMPAT 200 mg tablets (60-count) on October 27, 2025, with a ceiling value of $2,117.02. This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of October 28, 2025. The award represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of VIMPAT 200 mg/20 ml vials valued at $1,365.00. This is a firm fixed-price delivery order with an ultimate completion date of September 12, 2025, and represents a non-competitive set-aside award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 60 tablets of VIMPAT 100 mg at a ceiling value of $1,089.84 under a firm fixed price contract type. This award, issued on July 31, 2025, with an ultimate completion date of August 1, 2025, represents a non-set-aside competitive procurement. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order falls under the company's larger...
- The Defense Logistics Agency awarded a delivery order valued at $1,341.90 to AmerisourceBergen Drug Corp for the supply of VIMPAT 200 mg/20 mL vials. This competitive, non-set-aside contract was executed on November 17, 2025, with an ultimate completion date of November 18, 2025, and represents a firm fixed-price transaction. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order contract to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of VIMPAT 10 mg/mL solution in 200 mL quantities, valued at $1,959.86. This competitively awarded, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation and will...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,310.40 for VIMPAT 10 mg/mL Solution in a 200 mL quantity, with an ultimate completion date of August 20, 2025. This is a firm fixed price, non-set-aside contract awarded on August 19, 2025, with performance to be completed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. VIMPAT (lacosamide) is an antiepileptic medication used in the treatment of seizure disorders. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,689.20 to AmerisourceBergen Drug Corp for VIMPAT 200 mg tablets (60-count supply). This competitive, non-set-aside contract was awarded on September 25, 2025, with an ultimate completion date of September 26, 2025. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, under firm fixed-price terms. This delivery order is a child contract issued under AmerisourceBergen's...